Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials-Reference-Cited by-同舟云学术

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials

Published:2018-02 Issue:2 Volume:6 Page:117-126
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Bafadhel Mona,Peterson Stefan,De Blas Miguel A,Calverley Peter M,Rennard Stephen I,Richter Kai,Fagerås Malin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference29 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease;Global Initiative for Chronic Obstructive Lung Disease,2017

2. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns;Price;Int J Chron Obstruct Pulmon Dis,2014

3. Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and meta regression of randomized controlled trials;Agarwal;Chest,2010

4. Inhaled corticosteroids in COPD: the clinical evidence;Ernst;Eur Respir J,2015

5. Inhaled corticosteroids in COPD and the risk of serious pneumonia;Suissa;Thorax,2013

Cited by 296 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018;Biomedicines;2024-02-05

2. Blood eosinophil-guided therapy for COPD exacerbations;The Lancet Respiratory Medicine;2024-01

3. Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial;The Lancet Respiratory Medicine;2024-01

4. Reliability of blood eosinophil count in steady-state bronchiectasis;Pulmonology;2024-01

5. Eosinophils and therapeutic responses to steroids and biologics in COPD: a complex relationship;Jornal Brasileiro de Pneumologia;2023-12-06